The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems. © 2012 Ranganathan et al, publisher and licensee Dove Medical Press Ltd.
CITATION STYLE
Ranganathan, R., Madanmohan, S., Kesavan, A., Baskar, G., Krishnamoorthy, Y. R., Santosham, R., … Venkatraman, G. (2012). Nanomedicine: Towards development of patient-friendly drug-delivery systems for oncological applications. International Journal of Nanomedicine, 7, 1043–1060. https://doi.org/10.2147/IJN.S25182
Mendeley helps you to discover research relevant for your work.